Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
in vivo delivery
|
| gptkbp:developedBy |
gptkb:Beam_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
BEAM-301
|
| gptkbp:intendedUse |
treatment of glycogen storage disease type Ia
|
| gptkbp:mechanismOfAction |
base editing
|
| gptkbp:mode |
gene editing therapy
|
| gptkbp:status |
preclinical
|
| gptkbp:target |
gptkb:G6PC_gene
|
| gptkbp:bfsParent |
gptkb:Beam_Therapeutics
|
| gptkbp:bfsLayer |
5
|